Published in Arch Neurol on March 01, 1998
The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007. Cell Tissue Bank (2008) 4.13
Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol (2008) 3.39
Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol (2009) 2.67
A review of screening tests for cognitive impairment. J Neurol Neurosurg Psychiatry (2006) 2.09
C-reactive protein and familial risk for dementia: a phenotype for successful cognitive aging. Neurology (2012) 1.77
Validation of multi-stage telephone-based identification of cognitive impairment and dementia. BMC Neurol (2005) 1.63
The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y). Brain Res (2013) 1.44
Telephone-based identification of mild cognitive impairment and dementia in a multicultural cohort. Arch Neurol (2011) 1.15
Relationship between body height and dementia. Am J Geriatr Psychiatry (2005) 1.12
A Population-based study of dementia in the oldest old: the Monzino 80-plus study. BMC Neurol (2011) 0.81
Repetitive thinking as a psychological cognitive style in midlife is associated with lower risk for dementia three decades later. Dement Geriatr Cogn Disord (2009) 0.79
Religious education and midlife observance are associated with dementia three decades later in Israeli men. J Clin Epidemiol (2008) 0.78
Predictors of Optimal Cognitive Aging in 80+ Women: The Women's Health Initiative Memory Study. J Gerontol A Biol Sci Med Sci (2016) 0.77
Driving with Mild Cognitive Impairment or Dementia: Cognitive Test Performance and Proxy Report of Daily Life Function in Older Women. J Am Geriatr Soc (2015) 0.75
Increased longevity in offspring of mothers with Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2008) 0.75
Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women. Diabetes Care (2015) 0.75
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health (1998) 9.58
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med (1997) 7.56
Conservation conflicts across Africa. Science (2001) 7.09
Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science (1995) 6.58
A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. N Engl J Med (1992) 5.93
UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull (2001) 5.89
Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 4.31
Risk of Alzheimer's disease and duration of NSAID use. Neurology (1997) 4.06
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA (2000) 3.99
Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 3.74
Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci (1997) 3.61
Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience. Neurology (1997) 3.53
Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology (1988) 3.40
Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci (2000) 3.40
Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology (2001) 3.30
Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology (1996) 3.23
Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology (2003) 3.07
Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Arch Neurol (1992) 3.04
Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry (2001) 2.95
A validation study of the Dementia Questionnaire. Arch Neurol (1994) 2.89
Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA (2001) 2.79
A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology (2000) 2.76
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. Am J Geriatr Psychiatry (2001) 2.74
Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J Neurosci (1988) 2.73
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology (1995) 2.69
Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol (1997) 2.60
Late-onset schizophrenia: an overview. Schizophr Bull (1988) 2.58
Social skills performance assessment among older patients with schizophrenia. Schizophr Res (2001) 2.53
Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol (1989) 2.49
Risk factors for Parkinson's disease. Neurology (1993) 2.47
Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol (1997) 2.43
Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch Neurol (2000) 2.37
Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA (2001) 2.36
In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology (2007) 2.24
Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. Am J Pathol (1990) 2.24
An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. Neurology (2001) 2.20
Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry (2000) 2.19
Neocortical cell counts in normal human adult aging. Ann Neurol (1987) 2.16
Calcification of the basal ganglia: computerized tomography and clinical correlation. Neurology (1979) 2.14
Subthalamic deep brain stimulation and impulse control in Parkinson's disease. Eur J Neurol (2009) 2.13
Acute ascending necrotizing myelopathy caused by herpes simplex virus type 2. Neurology (1987) 2.11
Treatment of agitation in AD: a randomized, placebo-controlled clinical trial. Neurology (2000) 2.10
Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group. Am J Psychiatry (2000) 2.04
Enhancing informed consent for research and treatment. Neuropsychopharmacology (2001) 2.04
Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology (1997) 2.01
Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol (1997) 2.00
Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology (1998) 1.96
Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res (1997) 1.96
Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS (2000) 1.93
Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology (1995) 1.92
Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology (2000) 1.91
Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol (1994) 1.90
Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci Lett (1989) 1.89
Free testosterone and risk for Alzheimer disease in older men. Neurology (2004) 1.88
Neuroleptic withdrawal in schizophrenic patients. A review of the literature. Arch Gen Psychiatry (1995) 1.88
The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology (2004) 1.87
Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry (1999) 1.86
Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature (1993) 1.85
Depressive symptoms in schizophrenia. Am J Psychiatry (1999) 1.83
Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry (2005) 1.83
Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.80
Interactive video conferencing: a means of providing interim care to Parkinson's disease patients. Mov Disord (1993) 1.80
Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology (2008) 1.80
Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol (1987) 1.78
Cognitive training in Alzheimer's disease: a meta-analysis of the literature. Acta Psychiatr Scand (2006) 1.75
Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology (2004) 1.74
Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals. Neurology (2002) 1.74
Ultrastructural basis of the mechanism of rouleaux formation. Microvasc Res (1973) 1.72
Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study. Am J Respir Crit Care Med (2000) 1.71
Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology (2005) 1.70
Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry (1989) 1.69
Diagnostic accuracy of dementia with Lewy bodies. Arch Neurol (2000) 1.69
Essential role of neocortical acetylcholine in spatial memory. Nature (1995) 1.68
Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy? Ann Neurol (1991) 1.67
Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology (2007) 1.67
Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychol Aging (1999) 1.66
The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology (1996) 1.64
Schizophrenia in homeless persons: a systematic review of the literature. Acta Psychiatr Scand (2002) 1.63
New-onset psychosis in HIV-infected patients. J Clin Psychiatry (1991) 1.62
Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. N Engl J Med (1989) 1.59
Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology (1997) 1.58
Cholinergic dysfunction in diseases with Lewy bodies. Neurology (2000) 1.58